University of Dundee: Asthma trials

The registry lists 15 Asthma studies with University of Dundee as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 2Phase 4 11No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic RhinitisTerminatedNCT02953106Phase 4
• Ultra-long Acting Bronchodilator Therapy in Smoking AsthmaticsCompletedNCT02682862Phase 4
• Ultra-long Acting Bronchodilator Therapy in AsthmaticsCompletedNCT02039011Phase 4
• Targeted Small Airways Therapy in Persistent AsthmaCompletedNCT01894048Phase 4
• Effects of Particle Size in Small Airways DysfunctionCompletedNCT01892787Phase 4
• Beta Blocker Therapy in Mild to Moderate AsthmaticsCompletedNCT01544634Phase 2
• Steroid Titration Against Mannitol IN AsthmaCompletedNCT01216579Not applicable
• Beta Blockers for the Treatment of AsthmaCompletedNCT01074853Phase 2
• Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate AsthmaCompletedNCT00995657Phase 4
• Steroid Sparing Effect of Nasal Corticosteroid In Asthma And RhinitisCompletedNCT00903227Phase 4
• Trough Bronchoprotection Conferred by Levosalbutamol and Racemic SalbutamolCompletedNCT00831376Phase 4
• Peak Bronchoprotection Conferred by Levosalbutamol and Racemic SalbutamolWithdrawnNCT00830882Phase 4
• Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate AsthmaCompletedNCT00830505Phase 4
• Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory AsthmaCompletedNCT00829257Phase 4
• Add-on Salmeterol Versus Montelukast in Arg/Arg-16 AsthmaticsCompletedNCT00655616Not applicable